SURPASS PEDS
Study date: 01 September 2022
Status: Closed
Patients with type 2 diabetes (T2D) have above normal levels of glucose (sugar) in their blood. T2D is primarily diagnosed in adults however, there has been a significant increase of T2D in children and teens in recent years. Unlike adults, the children and teen population with T2D have fewer glucose-lowering treatment options that are regulatory approved. This study is investigating if a new medicine, called tirzepatide, is safe and effective for people with T2D between the ages of 10 and 18 years.
If you would like further information, please contact: PRCLeicester@uhl-tr.nhs.uk